📣 VC round data is live. Check it out!

Balsm Alofoq Valuation Multiples

Discover revenue and EBITDA valuation multiples for Balsm Alofoq and similar public comparables like Farmaceutica Remedia, Ortivus, iZafe Group, Etropal and more.

Balsm Alofoq Overview

About Balsm Alofoq

Balsm Alofoq Medical Co operates in the medical sector. Its activities include medical services, specialized clinics and medical complexes, medical operations, and the import and supply of medical devices and supplies to all regions of the Kingdom of Saudi Arabia.


Founded

2012

HQ

Saudi Arabia

Employees

N/A

Financials (FY)

Revenue: $6M
EBITDA: $1M

EV

$13M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Balsm Alofoq Financials

Balsm Alofoq reported last fiscal year revenue of $6M and EBITDA of $1M.

In the same fiscal year, Balsm Alofoq generated $2M in gross profit, $1M in EBITDA, and $535K in net income.


Balsm Alofoq P&L

In the most recent fiscal year, Balsm Alofoq reported revenue of $6M and EBITDA of $1M.

Balsm Alofoq is profitable as of last fiscal year, with gross margin of 38%, EBITDA margin of 19%, and net margin of 10%.

See analyst estimates for Balsm Alofoq
Last FY202320242025202620272028
Revenue$6M$5M$5M$6M
Gross Profit$2M$2M$3M$2M
Gross Margin38%45%47%38%
EBITDA$1M$2M$2M$1M
EBITDA Margin19%31%32%19%
EBIT Margin13%24%26%13%
Net Profit$535K$1M$1M$535K
Net Margin10%23%24%10%

Financial data powered by Morningstar, Inc.

Balsm Alofoq Stock Performance

Balsm Alofoq has current market cap of $15M, and enterprise value of $13M.

Market Cap Evolution


Balsm Alofoq's stock price is $6.18.

Balsm Alofoq share price increased by 1.6% in the last 30 days, and decreased by 39.0% in the last year.

Balsm Alofoq has an EPS (earnings per share) of $0.21.

See more trading valuation data for Balsm Alofoq
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13M$15M2.0%1.6%-17.0%-39.0%$0.21

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Balsm Alofoq Valuation Multiples

Balsm Alofoq trades at 2.3x EV/Revenue multiple, and 12.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Balsm Alofoq

Balsm Alofoq Financial Valuation Multiples

As of May 26, 2026, Balsm Alofoq has market cap of $15M and EV of $13M.

Balsm Alofoq has a P/E ratio of 28.9x.

Last FY202320242025202620272028
EV/Revenue2.3x2.6x2.4x2.3x
EV/EBITDA12.6x8.5x7.5x12.6x
EV/EBIT17.9x10.8x9.2x17.9x
EV/Gross Profit6.1x5.8x5.1x6.1x
P/E28.9x13.6x11.9x28.9x
EV/FCF(6.7x)(27.3x)9.0x(6.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Balsm Alofoq Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Balsm Alofoq Margins & Growth Rates

In the most recent fiscal year, Balsm Alofoq reported gross margin of 38%, EBITDA margin of 19%, and net margin of 10%.

See estimated margins and future growth rates for Balsm Alofoq

Balsm Alofoq Margins

Last FY20242025202720282029
Gross Margin38%47%38%
EBITDA Margin19%32%19%
EBIT Margin13%26%13%
Net Margin10%24%10%
FCF Margin(35%)27%(35%)

Balsm Alofoq Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth10%3%
Gross Profit Growth15%(17%)
EBITDA Growth13%(40%)
EBIT Growth17%(49%)
Net Profit Growth15%(59%)
FCF Growth(403%)(235%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Balsm Alofoq Operational KPIs

Access forward-looking KPIs for Balsm Alofoq
Last FY202320242025202620272028
S&M Expenses to Revenue3%8%8%3%
G&A Expenses to Revenue7%15%16%7%
Opex to Revenue25%21%21%25%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Balsm Alofoq Competitors

Balsm Alofoq competitors include Farmaceutica Remedia, Ortivus, iZafe Group, Etropal, Jin Medical International, BPC Instruments, Prolight Diagnostics, Airway Medix, BioRegenx and Cuprina Holdings (Cayman).

Most Balsm Alofoq public comparables operate across Medical Supplies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Farmaceutica Remedia0.0x1.0x
Ortivus2.4x(12.2x)
iZafe Group26.9x(14.3x)
Etropal1.4x17.9x
Jin Medical International0.4x8.2x
BPC Instruments1.7x7.7x
Prolight Diagnostics(4.4x)
Airway Medix11589.3x13.3x

This data is available for Pro users. Sign up to see all Balsm Alofoq competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Balsm Alofoq

When was Balsm Alofoq founded?Balsm Alofoq was founded in 2012.
Where is Balsm Alofoq headquartered?Balsm Alofoq is headquartered in Saudi Arabia.
Is Balsm Alofoq publicly listed?Yes, Balsm Alofoq is a public company listed on Tadawul.
What is the stock symbol of Balsm Alofoq?Balsm Alofoq trades under 9620 ticker.
When did Balsm Alofoq go public?Balsm Alofoq went public in 2024.
Who are competitors of Balsm Alofoq?Balsm Alofoq main competitors include Farmaceutica Remedia, Ortivus, iZafe Group, Etropal, Jin Medical International, BPC Instruments, Prolight Diagnostics, Airway Medix, BioRegenx, Cuprina Holdings (Cayman).
What is the current market cap of Balsm Alofoq?Balsm Alofoq's current market cap is $15M.
What is the current revenue of Balsm Alofoq?Balsm Alofoq's last fiscal year revenue is $6M.
What is the current EV/Revenue multiple of Balsm Alofoq?Current revenue multiple of Balsm Alofoq is 2.3x.
Is Balsm Alofoq profitable?No, Balsm Alofoq is not profitable.
How many companies Balsm Alofoq has acquired to date?Balsm Alofoq hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Balsm Alofoq has invested to date?Balsm Alofoq hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Balsm Alofoq

Lists including Balsm Alofoq

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial